Advertisement for orthosearch.org.uk
Results 1 - 1 of 1
Results per page:
Orthopaedic Proceedings
Vol. 105-B, Issue SUPP_17 | Pages 42 - 42
24 Nov 2023
IS DÉLAFLOXACINE A THERAPEUTIC OPTION FOR BONE AND JOINT INFECTIONS? A CRIOGO MULTICENTRE RETROSPECTIVE STUDY
Tessier E d'Epenoux Louise R Lartigue M Guerin F Plouzeau-Jayle C Tandé D Chenouard R Bemer P Corvec S
Full Access
View article

Abstract Background

The treatment of bone and joint infections (BJI) involving multi-drug resistant bacteria remains a challenge. MDR Staphylococcus epidermidis (MDRSE) clones, resistant to methicillin, clindamycin, levofloxacin, rifampicin and even linezolid, have been reported worldwide. The interest of delafloxacin (DFX), theoretically active on MRSA, remains to be evaluated with respect to MDRSE.

Purpose

Our objective was to evaluate during a retrospective multicenter study the DFX minimal inhibitory concentrations (MICs) and compare its efficacy between ofloxacin-susceptible and ofloxacin-resistant S. epidermidis clinical strains involved in BJI.

Image linking to Orthomedia